Ronaldo de Matos Esmeraldo, MD

Quick facts

Marketed products

• Low Tacrolimus · Immunology
  Low-dose tacrolimus is a calcineurin inhibitor that suppresses T-cell activation by blocking the phosphatase calcineurin, thereby reducing immune-mediated rejection and inflammation.
• Very Low Tacrolimus · Immunology / Transplantation
  Very Low Tacrolimus is a reduced-dose formulation of tacrolimus that suppresses T-cell activation by inhibiting calcineurin, thereby reducing transplant rejection while minimizing immunosuppressive toxicity.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Ronaldo de Matos Esmeraldo, MD portfolio CI brief
• Ronaldo de Matos Esmeraldo, MD pipeline updates RSS